These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11039780)

  • 1. Gene therapy for osteoarthritis: new perspectives for the twenty-first century.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S262-72. PubMed ID: 11039780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoarthritis gene therapy.
    Evans CH; Gouze JN; Gouze E; Robbins PD; Ghivizzani SC
    Gene Ther; 2004 Feb; 11(4):379-89. PubMed ID: 14724685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Marshall R. Urist Young Investigator Award. Orthopaedic applications of gene therapy. From concept to clinic.
    Kang R; Ghivizzani SC; Muzzonigro TS; Herndon JH; Robbins PD; Evans CH
    Clin Orthop Relat Res; 2000 Jun; (375):324-37. PubMed ID: 10853185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene.
    Frisbie DD; Ghivizzani SC; Robbins PD; Evans CH; McIlwraith CW
    Gene Ther; 2002 Jan; 9(1):12-20. PubMed ID: 11850718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10.
    Zhang X; Mao Z; Yu C
    J Orthop Res; 2004 Jul; 22(4):742-50. PubMed ID: 15183429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy in rheumatic diseases.
    Vervoordeldonk MJ; Tak PP
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):771-88. PubMed ID: 11812021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapeutic approaches-transfer in vivo.
    Evans CH; Gouze E; Gouze JN; Robbins PD; Ghivizzani SC
    Adv Drug Deliv Rev; 2006 May; 58(2):243-58. PubMed ID: 16563557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy in musculoskeletal repair.
    Nixon AJ; Goodrich LR; Scimeca MS; Witte TH; Schnabel LV; Watts AE; Robbins PD
    Ann N Y Acad Sci; 2007 Nov; 1117():310-27. PubMed ID: 18056051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy: what have we accomplished and where do we go from here?
    Evans CH
    J Rheumatol Suppl; 2005 Jan; 72():17-20. PubMed ID: 15660458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis.
    Scharstuhl A; Vitters EL; van der Kraan PM; van den Berg WB
    Arthritis Rheum; 2003 Dec; 48(12):3442-51. PubMed ID: 14673995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy.
    Nixon AJ; Haupt JL; Frisbie DD; Morisset SS; McIlwraith CW; Robbins PD; Evans CH; Ghivizzani S
    Gene Ther; 2005 Jan; 12(2):177-86. PubMed ID: 15578043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes.
    Adriaansen J; Vervoordeldonk MJ; Tak PP
    Rheumatology (Oxford); 2006 Jun; 45(6):656-68. PubMed ID: 16510530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
    Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
    Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Targeted anti-cytokine therapies for osteoarthritis].
    Chevalier X; Mugnier B; Bouvenot G
    Bull Acad Natl Med; 2006 Oct; 190(7):1411-20; discussion 1420, 1475-7. PubMed ID: 17450677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene therapy for osteoarticular disorders].
    Gouze JN; Evans CH; Ghivizzani SC; Gouze E
    Med Sci (Paris); 2007 Mar; 23(3):303-9. PubMed ID: 17349293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.